共 45 条
- [3] Comment on "Non-Proportional Hazards - an Evaluation of the MaxCombo Test in Cancer Clinical Trials" by the Cross-Pharma Non-Proportional Hazards Working Group STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (02): : 312 - 314
- [9] Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated BMC Medical Research Methodology, 16
- [10] Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated BMC MEDICAL RESEARCH METHODOLOGY, 2016, 16